Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing
Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing
复制标题
DOI：
10.1016/j.vaccine.2011.05.006
复制
发表时间：
2011-07-18
期刊：
影响因子：
5.5
通讯作者：
Lasset, C.
中科院分区：
文献类型：
--
作者：
Lutringer-Magnin, D.;Kalecinski, J.;Lasset, C.
目标人群对人乳头瘤病毒(HPV)疫苗的接受程度在很大程度上取决于它在医生中的可接受性。我们调查了全科医生对HPV疫苗接种的认知、态度和行为。从2007年11月到2008年4月，我们对法国大罗纳-阿尔卑斯地区具有代表性的5%的全科医生进行了横断面调查。调查采用定量(自填问卷)和定性(访谈)两种方法，在调查前一个月，在279名回应的全科医生中，75.6%的人至少接种了一次HPV疫苗，47.6%的人在14岁的常规目标年龄接种了HPV疫苗。总体而言，80.8%的全科医生对HPV疫苗表示好感，17.4%的人表示不确定，1.8%的人表示反对。对接种HPV疫苗的公共健康益处持好感的主要理由是(60%的赞成接种疫苗的人引用)。持“反对或不确定”观点的主要理由是最近引入了疫苗(43.4%的人引用)。提供HPV疫苗接种的主要困难是患者担心潜在的副作用(37%的受访者提到)和14岁的目标年龄(28.9%)。采访表明，对年龄的担忧可能与全科医生所认为的与青少年患者讨论性传播感染的需要有关。对HPV疫苗的好感与每周看到更多女性患者、年龄更小以及全科医生建议接种乙肝疫苗的意图有关。这项对法国主要地区全科医生的代表性调查发现，他们对HPV疫苗及其广泛使用持好感，尽管一些人担心，最近推出的疫苗意味着我们还不完全了解潜在的副作用和接受者的推荐目标年龄。(C)2011爱思唯尔有限公司。保留所有权利。
Acceptance of the Human Papillomavirus (HPV) vaccine by targeted populations will depend to a large extent on its acceptability among physicians. We examined the perceptions, attitudes and practices of general practitioners (GPs) in relation to HPV vaccination.From November 2007 to April 2008, a cross-sectional survey was carried out among a representative 5% sample of GPs in the large Rhone-Alpes region of France. Both quantitative (self-administered questionnaire) and qualitative (interview) approaches were used.During the month preceding the survey, 75.6% of the 279 GPs who responded had given at least one HPV vaccination and 47.6% had given a vaccination at the routine target age of 14 years. Overall, 80.8% of GPs reported a favourable opinion about HPV vaccination, 17.4% were uncertain and 1.8% were opposed. The main justification for a favourable opinion related to the public health benefits of the HPV vaccination (cited by 60% of those favouring vaccination). The main justification for an "opposed or uncertain" opinion was the too recent introduction of the vaccine (cited by 43.4%). The major difficulties in providing HPV vaccination were patients' concerns about potential side effects (cited by 37% of the respondents) and the target age of 14 years (28.9%). Interviews suggested that the concern about age may relate to the need, as perceived by GPs, to discuss sexually transmitted infections with adolescent patients. A favourable opinion about HPV vaccination was associated with seeing more female patients per week, younger age, and GPs' intention to recommend hepatitis B vaccination.This representative survey of GPs in a major region of France finds a favourable opinion about the HPV vaccine and widespread use of it, despite some concerns that the recent introduction of the vaccine means that we do not yet fully understand the potential for side effects and about the recommended target age of recipients. (C) 2011 Elsevier Ltd. All rights reserved.